AMAG Pharmaceuticals, Inc. (AMAG) Financial Statements (2023 and Earlier)

Company Profile

Business Address 1100 WINTER STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments172394329579466144
Cash and cash equivalents113253192274229119
Short-term investments5914113730523825
Receivables9485104928638
Inventory, net of allowances, customer advances and progress billings322737374141
Inventory322737374141
Other undisclosed current assets191912101451
Total current assets:317525482719607274
Noncurrent Assets
Inventory, Noncurrent     8
Operating lease, right-of-use asset23
Property, plant and equipment482624292
Intangible assets, net (including goodwill)4466401,3441,7321,836539
Goodwill423423639639639206
Intangible assets, net (excluding goodwill)242177041,0921,197334
Restricted cash and investments001332
Deferred income tax assets1
Other noncurrent assets 1111317
Other undisclosed noncurrent assets 1   546
Total noncurrent assets:4756501,3711,7601,8811,115
TOTAL ASSETS:7911,1751,8532,4782,4871,389
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21014418616011198
Accounts payable271410457
Accrued liabilities18313017515610681
Employee-related liabilities     10
Debt 21 211834
Restructuring reserve     2
Business combination, contingent consideration, liability0049  1
Deferred revenue and credits42352044
Other undisclosed current liabilities4  9797(13)
Total current liabilities:214165278313246166
Noncurrent Liabilities
Long-term debt and lease obligation297262735965986167
Long-term debt, excluding current maturities277262735965986167
Operating lease, liability20
Liabilities, other than long-term debt0151215198301
Deferred revenue and credits241556
Deferred tax liabilities, net 2419718978
Other liabilities01234 
Business combination, contingent consideration, liability 01  218
Other undisclosed noncurrent liabilities   51126294
Total noncurrent liabilities:2972637851,2311,309762
Total liabilities:5114291,0631,5441,555929
Stockholders' equity
Stockholders' equity attributable to parent280747790934932460
Common stock000000
Additional paid in capital1,2981,2931,2721,2381,234794
Accumulated other comprehensive loss(3)(4)(4)(4)(4)(4)
Accumulated deficit(1,015)(542)(478)(300)(298)(330)
Total stockholders' equity:280747790934932460
TOTAL LIABILITIES AND EQUITY:7911,1751,8532,4782,4871,389

Income Statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues327474610532418124
Revenue, net610532418124
Cost of revenue
(Cost of Goods and Services Sold)
(107)(216)(183)(117)(89)(22)
Gross profit:219258427415330102
Operating expenses(666)(305)(720)(336)(219)(113)
Other undisclosed operating income     7
Operating income (loss):(447)(47)(293)79111(4)
Nonoperating income (expense)(21)(83)(77)3(8)(14)
Investment income, nonoperating453321
Other nonoperating income (expense)0(0)(0)0(9) 
Interest and debt expense(26)(36)(11)(73)(64)(15)
Other undisclosed income from continuing operations before equity method investments, income taxes     15
Income (loss) from continuing operations before equity method investments, income taxes:(493)(166)(381)940(17)
Other undisclosed income from continuing operations before income taxes263611   
Income (loss) from continuing operations before income taxes:(468)(130)(370)940(17)
Income tax expense (benefit)0(40)171(12)(7)153
Income (loss) from continuing operations:(468)(169)(199)(2)33136
Income from discontinued operations 17    
Net income (loss):(468)(153)(199)(2)33136
Other undisclosed net income attributable to parent 87    
Net income (loss) available to common stockholders, diluted:(468)(66)(199)(2)33136

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(468)(153)(199)(2)33136
Comprehensive income (loss):(468)(153)(199)(2)33136
Other undisclosed comprehensive income (loss), net of tax, attributable to parent187(0)0(1)(0)
Comprehensive income (loss), net of tax, attributable to parent:(467)(66)(199)(2)32136

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: